Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro slows gastric emptying as part of how it works, meaning food moves through your stomach more gradually than it did before. For most people this means meals feel satisfying for longer, snacking urges quiet down, and blood-sugar spikes after eating are smaller. That shift happens because tirzepatide activates both GIP and GLP-1 receptors, two gut-hormone pathways involved in appetite signalling and the rate at which your stomach releases food into the small intestine. Understanding how your digestion changes on Mounjaro helps explain why some side effects appear, why certain foods feel heavier than usual, and how your body is adapting over the first weeks of treatment. These are prescription-only medicines, and a prescriber assesses whether Mounjaro is suitable for you before any treatment begins. For a broader picture of what to expect from treatment, the timeline of how long Mounjaro takes to work covers the full clinical picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When you eat on Mounjaro, the pyloric valve (the gateway between your stomach and small intestine) stays partially closed for longer than usual. Food that would ordinarily leave the stomach within two to four hours in an untreated adult may take considerably longer. Clinical studies of GLP-1 and dual GIP/GLP-1 receptor agonists consistently show meaningful delays in gastric emptying rate, and this is one of the primary mechanisms behind the reduced appetite that tirzepatide produces. The NHS medicines information for tirzepatide notes that slowing gastric emptying is a known pharmacological action of the drug.
In practical terms: you may find that a meal you would previously have forgotten about two hours later still feels present in your stomach at the three- or four-hour mark. That sustained fullness is the point. It is not a sign that something is wrong. What it does mean is that eating past the point of early satisfaction (something most people do habitually) can quickly tip into discomfort, bloating or nausea, because the stomach was already doing a slow job and you have added more work on top.
The effect is strongest during the first pen (the 2.5 mg starting phase) and after each step up in dose, simply because those are the moments when tirzepatide's action is most pronounced relative to what your body has adapted to. Understanding this sequence helps you make sense of how quickly the medicine takes effect in those early weeks.
There is a common misconception worth setting aside gently: many people assume that feeling uncomfortably full or nauseous on Mounjaro means the medicine is too strong or that something is going wrong. In most cases it reflects a digestive system that is still recalibrating, not a treatment that needs to stop.
The gastric-emptying effect does not disappear, but most people find it becomes more manageable over several weeks as eating habits shift to match the new digestive pace. Smaller, more frequent meals, slower eating, and cutting back on very fatty or rich foods all reduce the gap between what the stomach is being asked to do and how quickly it can do it. Adequate hydration matters here too, the intestinal phase of digestion, which handles absorption of nutrients from the small intestine outward, continues at a normal pace, so staying hydrated supports that downstream process even while the stomach gate is slower.
The side-effect profile during this phase is GI-led: nausea, fullness, occasional vomiting, reflux and constipation are the most commonly reported. NHS guidance on tirzepatide describes these as typically most noticeable after starting or a dose increase, with many people finding they settle within days to around two weeks. If symptoms are persistent or severe, the right move is a conversation with your prescriber, not self-managed dose adjustment. Our frequently asked questions cover some of the practical questions that come up during this period.
Slowed gastric emptying is not an inconvenience that accompanies Mounjaro's real work, it is part of the mechanism that produces weight loss. When food lingers in the stomach longer, gut-hormone signals that tell the brain you are full (including GLP-1 itself) remain elevated for an extended period. Appetite falls. Portion sizes drop naturally. Over weeks and months, a sustained calorie deficit follows.
In the SURMOUNT-1 trial, which followed adults with obesity over 72 weeks, participants on the highest dose of tirzepatide achieved an average body-weight reduction of around 20 to 21 percent, as published in the New England Journal of Medicine. The digestive slowdown is one of the physiological threads running through that result. For a closer look at how those weight-loss outcomes unfold week by week, the timeline page on weight-loss progress sets out what the evidence shows at each stage.
Longer-term, the goal is not a permanently upset stomach but a recalibrated relationship with food. Most people stabilise on a maintenance dose, their digestion adjusted, their habits shifted, and the earlier GI turbulence a distant memory, and if you are wondering how long you are likely to stay on Mounjaro altogether, that question is worth exploring before you begin. The detailed guide to food and digestion timing on Mounjaro goes further on what this means meal by meal. Cost and prescribing context for private treatment can be explored on the Mounjaro UK price comparison page.
Mounjaro is a prescription-only medicine. A GPhC-registered Independent Prescriber at our pharmacy reviews every consultation personally before treatment is issued. If you are considering starting treatment, start your free consultation to find out whether it is clinically appropriate for you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.